Comparison of 3D Conformal Proton Therapy, Intensity-Modulated Proton Therapy, and Intensity-Modulated Photon Therapy for Retroperitoneal Sarcoma. (19th March 2022)

• Record Type: Journal Article
• Authors: Chung, Christine; Trofimov, Alexei; Adams, Judith; Kung, Jong; Kirsch, David G.; Yoon, Sam; Doppke, Karen; Bortfeld, Thomas; Delaney, Thomas F.
• Other Names: Robinson Martin H. Academic Editor.
• Is Part Of: Sarcoma. Volume 2022(2022)
• Publication Date: 2022-03-19
• Subjects: Sarcoma -- Periodicals; 616.994
• DOI: 10.1155/2022/5540615
• Languages: English
• ISSNs: 1357-714X

Abstract

Abstract : Background . External beam radiation therapy (RT) for retroperitoneal sarcoma often requires treatment of large target volumes close to critical normal tissues. Radiation may be limited by adjacent organs at risk (OAR). Intensity-modulated radiation therapy has been shown to improve target coverage and reduce doses to OAR. Objectives . To compare target coverage and dose to OAR with 3D conformal proton therapy (3D CPT), intensity-modulated proton therapy (IMPT), and intensity-modulated photon therapy (IMXT). Methods . We performed a comparative study of treatment plans with 3D CPT, IMPT, and IMXT for ten patients with retroperitoneal sarcomas. RT was delivered to 50.4 Gy to the clinical target volume (CTV), the structures considered at risk for microscopic disease. Results . CTVs ranged from 74 to 357 cc (mean 188 cc). Dose conformity was improved with IMPT, while 3D CPT provided better dose homogeneity. Mean dose to the liver, small bowel, and stomach was reduced with IMPT compared with 3D CPT or IMXT. Conclusions . IMPT, 3D CPT, and IMXT provide excellent target coverage for retroperitoneal sarcomas. OAR dose is lower with IMPT and 3D CPT, and IMPT achieves the closest conformity. These techniques offer the opportunity for further dose escalation to areas with positive margins.